Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Centene Corp.

Related CNC
Top 4 Mid-Cap Stocks In The Health Care Plans Industry With The Highest ROI
Centene's Georgia Subsidiary Announces Successful Reprocurement of Georgia Medicaid Contract

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Centene Corp. (NYSE: CNC), and raised its price target from $44.00 to $46.00.

Jefferies noted, “CNC's direction from here hinges on the earnings power ex-KY, versus the costs to exit KY. We think earnings power outweighs; moreover, we will get a better picture of that the December I-Day. The incremental negative for exiting KY could be up to $2.75, but is unlikely to be clarified until well into 2013. We are raising our 2013 EPS estimates 10% and price target $2 to $46.”

Centene Corp. closed on Tuesday at $38.50.

Latest Ratings for CNC

Jul 2015UBSUpgradesNeutralBuy
Jul 2015Goldman SachsDowngradesNeutralSell
Jul 2015JefferiesUpgradesHoldBuy

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (CNC)

Get Benzinga's Newsletters